2 Feb
2021

The Roivant Sciences dealmaking strategy revolutionising life sciences IP monetisation

The trail-blazing biopharma company has pioneered a new model for monetising patents, setting important precedents for industry dealmaking

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth